Cassava Sciences Inc. sell nvestor
Start price
19.09.20
/
50%
€8.70
Target price
18.10.20
€4.00
Performance (%)
-4.90%
End price
18.10.20
€8.27
Summary
This prediction ended on 18.10.20 with a price of €8.27. With a performance of -4.90%, the SELL prediction for Cassava Sciences Inc. by nvestor was down slightly. nvestor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cassava Sciences Inc. | -8.626% | -8.626% | -6.402% | -93.747% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to nvestor what are the pros and cons of Cassava Sciences Inc. for the foreseeable future?
Pros
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Top Rating
High Investments for future growth
Management is a major shareholder
Well known brand
Very Future proof/growth oriented business model
Rising EBIT margin expected
Very high dividend yield expected
Very valuable balance sheet
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Very capable Management
Very good company culture
Leading role in innovation
Strong uniques
Very differentiated customer and product portfolio
Sustainability is very important
Small Risks for its business
Market Leader or Top 3
Very small cyclical dependencies
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Growths much faster than the competition
Undervalued
Cons
Comments by nvestor for this prediction
In the thread Cassava Sciences Inc. diskutieren
Sell mit Kursziel 4,0
In the thread Trading Cassava Sciences Inc.
Sell beendet
Stopped prediction by nvestor for Cassava Sciences Inc.
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€2.73
04.01.25
04.01.25
€282.00
04.01.26
04.01.26
-3.96%
18.01.25
18.01.25
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Top Rating
High Investments for future growth
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€2.33
29.12.24
29.12.24
€23.00
29.12.25
29.12.25
17.04%
04.01.25
04.01.25
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Top Rating
High Investments for future growth
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€3.02
08.12.24
08.12.24
€69.00
08.12.25
08.12.25
-27.06%
21.12.24
21.12.24
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Top Rating
High Investments for future growth
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€25.20
23.11.24
23.11.24
€12.00
23.11.25
23.11.25
-88.04%
07.12.24
07.12.24
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Top Rating
High Investments for future growth
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€25.72
28.09.24
28.09.24
€12.00
28.09.25
28.09.25
-4.63%
12.10.24
12.10.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€22.07
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-5.44%
27.04.24
27.04.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€2.48
23.12.19
23.12.19
€1.00
11.01.20
11.01.20
195.16%
11.01.20
11.01.20
Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating

